Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person
Arachidonic acid and/or compounds containing arachidonic acid as a constituent fatty acid are used to obtain compounds which prevent decline of, improve or enhance normal responses of cognitive abilities of a healthy person, and which are highly suitable for pharmaceuticals as well as food products, with minimal side effects.
1 . A composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person, containing arachidonic acid and/or a compound with arachidonic acid as a constituent fatty acid.
2 . A composition according to claim 1 , wherein the compound with arachidonic acid as a constituent fatty acid is an arachidonic acid alcohol ester or a triglyceride, phospholipid or glycolipid containing arachidonic acid as part or all of the constituent fatty acid.
3 . A composition according to claim 2 , wherein the triglyceride containing arachidonic acid as part or all of the constituent fatty acid is a triglyceride having medium-chain fatty acids bound at the 1,3-positions and arachidonic acid bound at the 2-position.
4 . A composition according to claim 3 , wherein the medium-chain fatty acids are selected from among fatty acids of 6 to 12 carbons.
5 . A composition according to claim 4 , wherein the medium-chain fatty acids are selected from among fatty acids of 8 carbons.
6 . A composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person, which contains triglycerides including triglycerides containing arachidonic acid as part or all of the constituent fatty acid.
7 . A composition according to claim 6 , characterized in that the arachidonic acid content of the triglycerides including triglycerides containing arachidonic acid as part or all of the constituent fatty acid is at least 10 wt % of the total fatty acid in the triglycerides.
8 . A composition according to claim 6 , wherein the triglycerides including triglycerides containing arachidonic acid as part or all of the constituent fatty acid are extracted from microbes belonging to the genus Mortierella.
9 . A composition according to claim 6 , wherein the triglycerides including triglycerides containing arachidonic acid as part or all of the constituent fatty acid are triglycerides containing no eicosapentaenoic acid or containing no more than 1% eicosapentaenoic acid.
10 . A composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person, which contains triglycerides including at least 5 mole percent of triglycerides with medium-chain fatty acids bound at the 1,3-positions and arachidonic acid bound at the 2-position.
11 . A composition according to claim 10 , wherein the medium-chain fatty acids are selected from among fatty acids of 6 to 12 carbons.
12 . A composition according to claim 11 , wherein the medium-chain fatty acids are selected from among fatty acids of 8 carbons.
13 . A composition according to claim 1 with effects of decline prevention, improvement or enhancement of the normal responses of a healthy person of processing speed or response speed with respect to events selected from the group consisting of auditory stimuli, visual stimuli, olfactory stimuli, gustatory stimuli and somatosensory stimuli, as a cognitive ability.
14 . A composition according to claim 1 with effects of decline prevention, improvement or enhancement of the normal response of concentration of a healthy person with respect to events selected from the group consisting of auditory stimuli, visual stimuli, olfactory stimuli, gustatory stimuli and somatosensory stimuli, as a cognitive ability.
15 . A composition according to claim 1 with effects of decline prevention, improvement or enhancement of the normal response of awareness level of a healthy person, as a cognitive ability.
16 . A composition according to claim 1 with effects of decline prevention, improvement or enhancement of the normal response of discriminatory ability of a healthy person with respect to events selected from the group consisting of auditory stimuli, visual stimuli, olfactory stimuli, gustatory stimuli and somatosensory stimuli, as a cognitive ability.
17 . A composition according to claim 1 with an effect of shortening P300 latency of the event related potentials of brain (P300), as a response index of cognitive ability.
18 . A composition according to claim 1 with an effect of augmenting the P300 amplitude of the event related potentials of brain (P300), as a response index of cognitive ability.
19 . A composition according to claim 1 , wherein the composition is a food composition or pharmaceutical composition.
20 . A food composition containing arachidonic acid and/or a compound with arachidonic acid as a constituent fatty acid, in an amount such that the daily ingestion for an adult is 0.001-20 g in terms of arachidonic acid.
21 . A food composition according to claim 20 , wherein the compound with arachidonic acid as a constituent fatty acid is an arachidonic acid alcohol ester or a triglyceride, phospholipid or glycolipid comprising arachidonic acid as part or all of the constituent fatty acid.
22 . A food composition according to claim 21 , wherein the triglyceride containing arachidonic acid as part or all of the constituent fatty acid is a triglyceride having medium-chain fatty acids bound at the 1,3-positions and arachidonic acid bound at the 2-position.
23 . A food composition according to claim 22 , wherein the medium-chain fatty acids are selected from among fatty acids of 6 to 12 carbons.
24 . A food composition according to claim 23 , wherein the medium-chain fatty acids are selected from among fatty acids of 8 carbons.
25 . A food composition characterized in that the composition contains at least 0.001 wt % of triglycerides having medium-chain fatty acids bound at the 1,3-positions and arachidonic acid bound at the 2-position.
26 . A food composition according to claim 25 , wherein the medium-chain fatty acids are selected from among fatty acids of 6 to 12 carbons.
27 . A food composition according to claim 26 , wherein the medium-chain fatty acids are selected from among fatty acids of 8 carbons.
28 . A composition according to claim 20 , wherein the food composition is a functional food, nutritional supplement food, special health care food or geriatric food.
29 . A composition according to claim 1 , which further comprises docosahexaenoic acid and/or a compound with docosahexaenoic acid as a constituent fatty acid.
30 . A composition according to claim 29 , wherein the compound with docosahexaenoic acid as a constituent fatty acid is a docosahexaenoic acid alcohol ester or a triglyceride, phospholipid or glycolipid comprising docosahexaenoic acid as part or all of the constituent fatty acid.
31 . A composition according to claim 29 , wherein the arachidonic acid/docosahexaenoic acid ratio (by weight) in a combination of the arachidonic acid and docosahexaenoic acid is in the range of 0.1-15.
32 . A composition according to claim 1 , wherein eicosapentaenoic acid is also present in composition in an amount not exceeding ⅕ of the arachidonic acid in the composition.
33 . A process for production of a food composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person, comprising combining arachidonic acid and/or a compound with arachidonic acid as a constituent fatty acid, either alone or with a food material containing either essentially no or only a trace amount of arachidonic acid.
34 . A method for marketing a composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person containing arachidonic acid and/or a compound with arachidonic acid as a constituent fatty acid, the method for marketing a composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person comprising using a packaging container and/or merchandising tool which indicates that the composition and/or components in the composition have effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person.
35 . A composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person, comprising composition containing arachidonic acid and/or a compound with arachidonic acid as a constituent fatty acid which is marketed using a packaging container and/or merchandising tool for the composition indicating that the composition and/or components in the composition have effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person.